Last reviewed: June 19, 2026
Last updated: June 19, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide reaches peak effectiveness when injected into subcutaneous tissue—the fatty layer between skin and muscle. Proper injection technique not only ensures the medication absorbs correctly but also reduces injection site reactions and pain. PlexusDx provides step-by-step guidance so patients can confidently self-administer their weekly doses at home.
Subcutaneous vs. Other Injection Routes: Why Location Matters
Semaglutide must be injected subcutaneously, meaning into the fatty tissue just beneath the skin's outer layer. This route allows the medication to be absorbed slowly and steadily into the bloodstream over several days, matching the once-weekly dosing schedule that makes weight loss therapy practical. Intramuscular or intravenous injection would cause the drug to enter circulation too quickly, reducing its duration of action and therapeutic window.
The subcutaneous route is preferred because it minimizes peak drug concentrations that can trigger nausea and other gastrointestinal side effects. Clinical data shows that consistent subcutaneous delivery maintains stable GLP-1 receptor activation throughout the week, supporting appetite suppression and metabolic benefits. PlexusDx patients are trained to identify and use appropriate subcutaneous sites before their first injection.
Approved Injection Sites: Abdomen, Thigh, and Upper Arm
The abdomen, front of the thigh, and back of the upper arm are the three FDA-approved locations for semaglutide injection. Each area contains adequate subcutaneous fat and is easily accessible for self-injection. The abdomen offers the largest injection area and is often the easiest site for patients to visualize and reach without assistance or mirrors.
The outer thigh provides an alternative when abdominal injection sites need a break, and the back of the upper arm works well for patients who prefer less visible injection locations. Rotating between these three areas reduces the risk of lipodystrophy—abnormal fat changes that can occur if the same spot receives repeated injections. PlexusDx recommends spacing injections at least one inch apart and waiting at least two weeks before reusing the same site.
Proper Needle Depth and Injection Angle for Optimal Absorption
Semaglutide pens and needles are designed for a 45- to 90-degree angle injection into subcutaneous tissue. Most patients use a 4mm or 6mm needle, which reaches the appropriate depth—approximately one-quarter inch below the skin surface—without hitting muscle underneath. Inserting the needle at too shallow an angle may deposit medication into the dermis (the skin layer itself), delaying absorption and increasing local irritation.
Inserting at a steeper angle (closer to perpendicular) generally produces more consistent delivery into the subcutaneous layer. The pinch technique—gently lifting a fold of skin and fat before injection—helps ensure the needle travels through the dermis into subcutaneous tissue. PlexusDx training materials include visual guides and practice tips to help patients develop proper technique and build confidence before their first live injection.
Site Rotation Strategy and Managing Injection Site Reactions
Rotating injection sites reduces inflammation, bruising, and the formation of hard lumps (nodules) beneath the skin. A systematic rotation plan—such as using the abdomen on weeks 1 and 5, the right thigh on weeks 2 and 6, the left thigh on weeks 3 and 7, and the upper arm on week 4—ensures even distribution across approved areas. This pattern allows each site at least two weeks of recovery between injections at the same location.
Mild redness, swelling, or bruising at the injection site typically resolves within a few hours to days and does not indicate improper technique. However, patients should avoid injecting through scar tissue, areas with visible bruising, or patches of skin that appear irritated or sensitive. If a patient develops persistent nodules, significant swelling, or signs of infection, they should contact PlexusDx support immediately. Compounded semaglutide from licensed 503A pharmacies uses the same sterile preparation as brand-name versions, minimizing contamination risk when proper aseptic technique is followed.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Can I inject semaglutide anywhere on my body?
No. Semaglutide must be injected into the abdomen, front of the thigh, or back of the upper arm. These areas have adequate subcutaneous fat to ensure proper absorption. Injecting in other locations may result in poor medication delivery or tissue damage. PlexusDx provides a visual site map during the onboarding consultation.
What happens if I inject semaglutide into muscle instead of fat?
Intramuscular injection would cause the medication to enter the bloodstream too rapidly, potentially increasing nausea and side effects while reducing the medication's duration of action. The once-weekly dosing schedule relies on slow subcutaneous absorption. If you suspect an injection entered muscle, contact PlexusDx to discuss your technique and next steps.
How much does PlexusDx compounded semaglutide cost compared to the brand name?
PlexusDx compounded semaglutide injection starts at $149 per month across all dose levels. Your dose may need to go up. Your price won't. No insurance is required, and HSA and FSA accounts are accepted. Pricing remains flat regardless of the strength or volume your provider prescribes.
Is injection site bruising a sign something went wrong?
Minor bruising is normal and does not indicate improper injection technique. It typically fades within several days. However, persistent swelling, hard lumps, or signs of infection warrant immediate medical attention. Using proper needle depth, angle, and site rotation minimizes bruising risk over time.
Can the Precision Peptide Genetic Test help predict how my body will respond to semaglutide?
Yes. PlexusDx Precision Peptide Genetic Test ($99 add-on after first month) analyzes variants in GLP1R, GIPR, FTO, and MC4R genes across 14 metabolic pathways to identify your peptide response profile. Patients with certain GLP1R variants may show enhanced appetite suppression, while FTO variants may influence baseline weight set-point sensitivity. This data helps personalize your therapy from the start.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Is Wegovy Good for Diabetics? Exploring Benefits and Considerations
What Is the Drug in Ozempic That Causes Weight Loss?